This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Alberta, CA (2014)
- Edmonton, CA (2016)
Company Filing History:
Years Active: 2014-2016
Title: Dazhan Liu: Innovator in Antiviral Therapies
Introduction
Dazhan Liu is a prominent inventor based in California, known for his significant contributions to antiviral therapies. With a focus on innovative solutions for combating viral infections, Liu has made notable advancements in the field of medicine.
Latest Patents
Liu holds 2 patents, including his latest work on Tenofovir alafenamide hemifumarate. This patent describes a hemifumarate form of 9-[(R)-2-[[[S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide). Additionally, he has developed antiviral therapy using tenofovir alafenamide hemifumarate, which is applicable in anti-HIV and anti-HBV therapies.
Career Highlights
Dazhan Liu is currently associated with Gilead Sciences, Inc., where he continues to work on groundbreaking research in antiviral treatments. His expertise and innovative approach have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Liu has collaborated with notable colleagues, including Fang Wang and Richard Hung Chiu Yu. These partnerships have fostered a collaborative environment that enhances the development of effective antiviral therapies.
Conclusion
Dazhan Liu's contributions to antiviral therapies and his innovative patents underscore his importance in the field of medicine. His work continues to impact the fight against viral infections, making him a significant figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile